https://scholars.lib.ntu.edu.tw/handle/123456789/202486
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor | 檢驗醫學科 | en |
dc.contributor.author | HSUEH, PO-REN | en |
dc.creator | 薛博仁 | zh-tw |
dc.creator | HSUEH, PO-REN | en |
dc.date | 2009 | en |
dc.date.accessioned | 2010-07-08T05:55:11Z | - |
dc.date.accessioned | 2018-07-12T09:29:49Z | - |
dc.date.available | 2010-07-08T05:55:11Z | - |
dc.date.available | 2018-07-12T09:29:49Z | - |
dc.date.issued | 2009 | - |
dc.identifier.uri | http://ntur.lib.ntu.edu.tw//handle/246246/188779 | - |
dc.description.abstract | Human papillomavirus (HPV)-related diseases, including cancers, low-grade neoplasia, genital warts, and recurrent respiratory papillomatosis, have a substantial impact on public health. The increasing incidence of HPV infection and genital warts highlights the need for an effective strategy for the management of this disease. Immunization holds the promise of reducing the overall burden of clinical HPV- related diseases. A prophylactic quadrivalent HPV 6/11/16/18 vaccine is highly effective for reducing the risk of HPV 6- , 11-, 16-, and 18-associated cervical cancer, precancerous cervical lesions, and external genital lesions, including genital warts. | en |
dc.language | en-us | en |
dc.language.iso | en_US | - |
dc.relation | JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION v.42 n.2 pp.101-106 | en |
dc.relation.ispartof | JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION | - |
dc.subject | Condylomata acuminata | en |
dc.subject | Human papillomavirus | en |
dc.subject | Papillomavirus vaccines | en |
dc.subject.classification | [SDGs]SDG3 | - |
dc.title | Human Papillomavirus, Genital Warts, and Vaccines | en |
dc.relation.pages | 101-106 | - |
dc.relation.journalvolume | v.42 | - |
dc.relation.journalissue | n.2 | - |
item.languageiso639-1 | en_US | - |
item.grantfulltext | none | - |
item.fulltext | no fulltext | - |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。